Clinically Apparent Atrial Fibrillation Increases Stroke Risk; Does Subclinical AFib Do the Same?

Published Online: Tuesday, January 14, 2014
Follow Pharmacy_Times:
Stuart J. Connelly, MD, one of the principal authors of “Subclinical Atrial Fibrillation and the Risk of Stroke,” published in the New England Journal of Medicine, talks about the study.  

To listen to the podcast, click here.
Related Articles
Lundbeck will cease further development of its experimental desmoteplase compound for ischemic stroke.
Aaron Steffenhagen, PharmD, BCPS, a clinical pharmacy manager at the University of Wisconsin Hospital, discusses what areas pharmacists should focus on during acute stroke codes.
Aaron Steffenhagen, PharmD, BCPS, a clinical pharmacy manager at the University of Wisconsin Hospital, discusses a pharmacist's door-to-door discharge role when managing an ischemic stroke patient.
Aaron Steffenhagen, PharmD, BCPS, a clinical pharmacy manager at the University of Wisconsin Hospital, discusses how pharmacists can enhance stroke care.
Latest Issues
$auto_registration$